Current Value
$6.791 Year Return
Current Value
$6.791 Year Return
SeekingAlpha
The preferred shares of Summit Hotel Properties offer investors cumulative dividends. Read how preferreds in this REIT fit into a portfolio.
Yahoo
Summit Hotel Properties, Inc. (NYSE: INN) (the "Company") today announced that it will report financial results for the fourth quarter and full year of 2024 on Monday, February 24, 2025, after the market closes.
Yahoo
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that the FDA's Center for Veterinary Medicine (CVM) has granted the Company a sponsor fee waiver for its LPT-CBD (Liposome Platform Technology-Cannabidiol) product for the second consecutive year.
Yahoo
Innocan Pharma Corporation (the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that it has closed its previously announced non-brokered private placement offering (the "Offering") of units of the Company (the "Units"), pursuant to which the Company issued 3,177,223 Units at a price of C$0.20 per Unit (the "Offering Price") for aggregate gross proceeds of $635,444.60.
Yahoo
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it intends to complete a non-brokered private placement of up to [3,500,000] units of the Company (the "Units") at a price of [C$0.20] per Unit for gross proceeds up to C$700,000 plus 15% over allotment options (the "Offering"). The Offering is expected to close on or around December 31, 2024.
Yahoo
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies and an owner of a proprietary intellectual property portfolio, is pleased to share its annual "State of Research and Development" update for 2024. This year, the Company achieved significant milestones in advancing research and development for its drug delivery platforms as well as its intellectual
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IRBT | -0.09% | $253.64M | -64.86% | 0.00% |
CATO | 0.16% | $76.81M | -47.47% | 13.42% |
TLPH | 0.24% | $10.56M | -36.02% | 0.00% |
AVDL | 0.33% | $770.89M | -46.81% | 0.00% |
QXO | 0.50% | $5.61B | -84.92% | 0.00% |
COR | 0.54% | $46.56B | +9.10% | 0.86% |
KMB | -0.57% | $42.24B | +2.93% | 3.86% |
MRK | 0.65% | $254.73B | -15.05% | 3.10% |
XBIO | -0.68% | $6.56M | +24.36% | 0.00% |
AEP | -0.73% | $51.56B | +23.81% | 3.67% |
LTM | -0.74% | $8.28B | -100.00% | <0.01% |
GL | 0.81% | $9.84B | -2.89% | 0.82% |
ROOT | 0.83% | $1.33B | +867.47% | 0.00% |
PGNY | 0.90% | $1.76B | -45.99% | 0.00% |
POAI | 1.05% | $8.93M | -50.74% | 0.00% |
NHTC | 1.05% | $53.19M | -24.39% | 17.24% |
HRL | 1.18% | $16.41B | -3.83% | 3.81% |
BTCT | 1.20% | $23.92M | +5.78% | 0.00% |
IMAB | 1.38% | $84.73M | -31.89% | 0.00% |
PEP | -1.40% | $201.05B | -12.34% | 3.61% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -15.95% | $20.30B | +3.74% | 1.22% |
HUSA | -12.43% | $22.51M | +5.52% | 0.00% |
AMED | -10.70% | $3.01B | -3.13% | 0.00% |
CYD | -10.16% | $424.11M | +15.33% | 3.62% |
CYCN | -9.40% | $7.89M | -19.17% | 0.00% |
PG | -8.91% | $377.98B | +8.34% | 2.48% |
CHD | -8.55% | $26.04B | +8.63% | 1.06% |
SRRK | -7.61% | $4.11B | +176.62% | 0.00% |
HIHO | -6.75% | $8.43M | -6.13% | 6.27% |
ASPS | -6.46% | $18.10M | -74.23% | 0.00% |
UUU | -6.42% | $5.41M | +48.10% | 0.00% |
MCK | -5.55% | $75.55B | +20.73% | 0.45% |
OXBR | -4.88% | $24.62M | +287.75% | 0.00% |
BACK | -4.31% | $2.66M | -40.81% | 0.00% |
VIRT | -3.98% | $3.17B | +96.96% | 2.59% |
VSTA | -3.78% | $188.40M | -44.05% | 0.00% |
DOGZ | -3.70% | $562.95M | +1,227.93% | 0.00% |
MSDL | -3.57% | $1.89B | +3.99% | 9.39% |
CPSH | -3.55% | $25.57M | -23.14% | 0.00% |
MANU | -3.39% | $2.75B | -19.60% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DRH | 83.19% | $1.87B | -0.75% | 1.32% |
RLJ | 82.05% | $1.53B | -12.05% | 4.95% |
APLE | 76.66% | $3.62B | -6.32% | 6.32% |
PEB | 75.16% | $1.64B | -10.57% | 0.29% |
PK | 73.57% | $2.81B | -12.62% | 7.32% |
SHO | 72.21% | $2.35B | +10.90% | 2.90% |
HST | 71.13% | $11.93B | -12.50% | 4.66% |
XHR | 70.87% | $1.52B | +15.26% | 3.17% |
CLDT | 69.71% | $429.93M | -15.56% | 3.14% |
RHP | 68.38% | $6.17B | -8.31% | 4.26% |
SVC | 62.17% | $424.95M | -68.32% | 23.60% |
TNL | 56.55% | $3.56B | +32.66% | 3.82% |
PGRE | 55.27% | $996.24M | +0.22% | 1.50% |
H | 53.61% | $14.88B | +19.60% | 0.38% |
AIT | 53.39% | $9.82B | +47.99% | 0.57% |
AVNT | 53.11% | $3.79B | +14.06% | 2.48% |
HGV | 53.00% | $3.86B | -5.42% | 0.00% |
IOSP | 52.55% | $2.82B | -3.69% | 1.36% |
VAC | 51.80% | $2.97B | +2.47% | 3.56% |
MAR | 51.79% | $76.70B | +18.62% | 0.86% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SPSM | 61.80% | $12.42B | 0.03% |
IJR | 61.80% | $88.71B | 0.06% |
PRFZ | 61.68% | $2.54B | 0.39% |
VIOV | 61.50% | $1.42B | 0.15% |
IJT | 61.47% | $6.59B | 0.18% |
VIOO | 61.45% | $3.13B | 0.1% |
IJS | 61.38% | $7.61B | 0.18% |
ESML | 61.29% | $1.92B | 0.17% |
RWJ | 61.28% | $1.76B | 0.39% |
EZM | 61.26% | $860.71M | 0.38% |
IVOV | 61.21% | $939.85M | 0.15% |
JMEE | 61.16% | $1.69B | 0.24% |
MDYV | 61.03% | $2.76B | 0.15% |
SLYG | 60.89% | $3.65B | 0.15% |
VBR | 60.88% | $31.69B | 0.07% |
NUSC | 60.84% | $1.23B | 0.31% |
SLYV | 60.82% | $3.96B | 0.15% |
IJJ | 60.70% | $8.53B | 0.18% |
SMLF | 60.63% | $1.56B | 0.15% |
IWN | 60.61% | $12.34B | 0.24% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -33.63% | $195.31M | 0.85% |
TAIL | -29.40% | $65.23M | 0.59% |
USDU | -18.96% | $396.64M | 0.5% |
UUP | -14.71% | $636.64M | 0.77% |
WEAT | -9.57% | $121.95M | 0.28% |
KMLM | -9.52% | $330.04M | 0.9% |
IBMN | -6.96% | $484.25M | 0.18% |
CTA | -6.57% | $553.08M | 0.76% |
MEAR | -5.81% | $777.56M | 0.25% |
IBD | -5.20% | $337.54M | 0.44% |
ULST | -4.17% | $549.72M | 0.2% |
CORN | -3.45% | $65.53M | 0.2% |
JUCY | -2.38% | $299.79M | 0.6% |
DBA | -2.00% | $817.28M | 0.93% |
DBE | -1.98% | $50.40M | 0.77% |
YEAR | -1.51% | $1.19B | 0.25% |
BUXX | -1.02% | $197.67M | 0.25% |
PWZ | -0.91% | $695.89M | 0.28% |
USCI | 0.07% | $201.05M | 1.07% |
CCOR | 0.98% | $82.79M | 1.18% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
USCI | 0.07% | $201.05M | 1.07% |
PWZ | -0.91% | $695.89M | 0.28% |
CCOR | 0.98% | $82.79M | 1.18% |
BUXX | -1.02% | $197.67M | 0.25% |
YEAR | -1.51% | $1.19B | 0.25% |
TBLL | 1.63% | $1.98B | 0.08% |
DBO | 1.69% | $220.74M | 0.77% |
DBE | -1.98% | $50.40M | 0.77% |
DBA | -2.00% | $817.28M | 0.93% |
COMT | 2.28% | $714.17M | 0.48% |
HYMB | 2.28% | $2.79B | 0.35% |
JUCY | -2.38% | $299.79M | 0.6% |
XBIL | 2.64% | $643.80M | 0.15% |
AGZD | 2.87% | $148.43M | 0.23% |
VRIG | 2.95% | $1.20B | 0.3% |
BOXX | 2.99% | $4.76B | 0.1949% |
SGOV | 3.11% | $31.44B | 0.09% |
PDBC | 3.15% | $4.40B | 0.59% |
CORN | -3.45% | $65.53M | 0.2% |
CGMU | 3.52% | $2.72B | 0.27% |